Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

JNK2 Antikörper (N-Term)

MAPK9 Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN293094
  • Target Alle JNK2 (MAPK9) Antikörper anzeigen
    JNK2 (MAPK9) (Mitogen-Activated Protein Kinase 9 (MAPK9))
    Bindungsspezifität
    • 9
    • 8
    • 7
    • 6
    • 6
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 72
    • 43
    • 31
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 57
    • 8
    • 3
    • 2
    • 1
    Kaninchen
    Klonalität
    • 57
    • 16
    Polyklonal
    Konjugat
    • 42
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser JNK2 Antikörper ist unkonjugiert
    Applikation
    • 51
    • 34
    • 29
    • 11
    • 10
    • 10
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Marke
    IHC-plus™
    Spezifität
    Synthetic peptide corresponding to N-terminal residues of human MAPK9(Mitogen-activated protein kinase 9)
    Aufreinigung
    Immunoaffinity purified
    Immunogen
    Synthetic peptide from human MAPK9 / JNK2.

    Type of Immunogen: Synthetic peptide
    Top Product
    Discover our top product MAPK9 Primärantikörper
  • Applikationshinweise
    Approved: ELISA (1 μg/mL), IHC, IHC-P (20 μg/mL), WB (1 μg/mL)

    Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in  pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 20 μg/mL.
    Kommentare

    Target Species of Antibody: Human

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    PBS, 0.01 % sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
  • Target
    JNK2 (MAPK9) (Mitogen-Activated Protein Kinase 9 (MAPK9))
    Andere Bezeichnung
    MAPK9 / JNK2 / SAPK (MAPK9 Produkte)
    Synonyme
    MAPK9 antikoerper, JNK-55 antikoerper, JNK2 antikoerper, JNK2A antikoerper, JNK2ALPHA antikoerper, JNK2B antikoerper, JNK2BETA antikoerper, PRKM9 antikoerper, SAPK antikoerper, SAPK1a antikoerper, p54a antikoerper, p54aSAPK antikoerper, AI851083 antikoerper, Prkm9 antikoerper, JNK2-ALPHA1 antikoerper, MAP kinase 9 antikoerper, mitogen-activated protein kinase 9 antikoerper, MAP kinase 9 antikoerper, MAPK9 antikoerper, Mapk9 antikoerper, MPK9 antikoerper
    Hintergrund
    Name/Gene ID: MAPK9
    Subfamily: MAPK
    Family: Protein Kinase

    Synonyms: MAPK9, C-Jun kinase 2, C-Jun N-terminal kinase 2, JNK2B, JNK2, JNK2ALPHA, MAP kinase 9, p54a, JNK2BETA, PRKM9, SAPK, MAPK 9, p54aSAPK, SAPK1a, JNK-55, JNK2A, Jun kinase
    Gen-ID
    5601
    UniProt
    P45984
    Pathways
    MAPK Signalweg, WNT Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Endopeptidase Activity, Hepatitis C, Toll-Like Receptors Cascades, BCR Signaling, S100 Proteine
Sie sind hier:
Kundenservice